Ben Beneski

Outlook Microsoft Office 365 Google Font API Gravity Forms Mobile Friendly Google Tag Manager Facebook Custom Audiences Nginx Open AdStream (Appnexus) Facebook Widget Facebook Login (Connect) Vimeo Google Analytics Linkedin Marketing Solutions WordPress.org Render Micro IoT Remote AI

oncology cancer biotechnology immunotherapy car t autoimmune biotechnology: biological products (no diagnostic substances) health care allocar t cell therapy autoimmune disease cancer treatment chimeric antigen receptor off-the-shelf investigational products multiplex gene-editing lymphodepletion clinical trials phase 1 trial phase 2 trial fda designation therapeutic advancements allogeneic car t manufacturing capabilities drug development patient access innovative medicines cancer immunotherapy treatment optimization commercialization strategy research & development preclinical data cemacabtagene ansegedleucel allo-316 allo-329 dual car t gene editing clinical-stage company management team investment opportunities financial results stock information corporate governance scientific publications healthcare conferences biopharmaceutical innovations on-demand therapy publications regenerative medicine disease targets therapeutic candidates clinical effectiveness patient-centric approach pipeline strategy collaborative research business development allogeneic car t cell therapy off-the-shelf treatments autoimmune diseases hematological malignancies solid tumors multiplex gene editing proprietary lymphodepletion platform innovative biotechnology patient accessibility scalable manufacturing fda fast track designation diversity & inclusion healthcare providers oncologists biopharmaceutical industry patient outcomes hospital & health care health wellness & fitness b2b